Correlation Between Kancera AB and Oncopeptides
Can any of the company-specific risk be diversified away by investing in both Kancera AB and Oncopeptides at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kancera AB and Oncopeptides into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kancera AB and Oncopeptides AB, you can compare the effects of market volatilities on Kancera AB and Oncopeptides and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kancera AB with a short position of Oncopeptides. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kancera AB and Oncopeptides.
Diversification Opportunities for Kancera AB and Oncopeptides
0.92 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Kancera and Oncopeptides is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding Kancera AB and Oncopeptides AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncopeptides AB and Kancera AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kancera AB are associated (or correlated) with Oncopeptides. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncopeptides AB has no effect on the direction of Kancera AB i.e., Kancera AB and Oncopeptides go up and down completely randomly.
Pair Corralation between Kancera AB and Oncopeptides
Assuming the 90 days trading horizon Kancera AB is expected to generate 2.14 times more return on investment than Oncopeptides. However, Kancera AB is 2.14 times more volatile than Oncopeptides AB. It trades about -0.01 of its potential returns per unit of risk. Oncopeptides AB is currently generating about -0.13 per unit of risk. If you would invest 175.00 in Kancera AB on September 15, 2024 and sell it today you would lose (65.00) from holding Kancera AB or give up 37.14% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Kancera AB vs. Oncopeptides AB
Performance |
Timeline |
Kancera AB |
Oncopeptides AB |
Kancera AB and Oncopeptides Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Kancera AB and Oncopeptides
The main advantage of trading using opposite Kancera AB and Oncopeptides positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kancera AB position performs unexpectedly, Oncopeptides can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncopeptides will offset losses from the drop in Oncopeptides' long position.Kancera AB vs. Combigene AB | Kancera AB vs. Cantargia AB | Kancera AB vs. Fingerprint Cards AB | Kancera AB vs. Spectrumone publ AB |
Oncopeptides vs. Mendus AB | Oncopeptides vs. Cantargia AB | Oncopeptides vs. BioInvent International AB | Oncopeptides vs. Isofol Medical AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Transaction History View history of all your transactions and understand their impact on performance | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |